I-Mirvetuximab soravtansine-gynx igunyazwe yi-USFDA nge-FRα positive, i-platinum-resistant epithelial ovarian, fallopian tube, noma umdlavuza we-peritoneal oyinhloko.

March 2024: The Food and Drug Administration has granted approval for mirvetuximab soravtansine-gynx (Elahere, ImmunoGen, Inc. [now a part of AbbVie]) to be used in adult patients with FRα positive, platinum-resistant epithelial ..

Izivivinyo zemitholampilo

I-MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer

Mashi 2023: Isifinyezo esifushane: Injongo yalolu cwaningo lomtholampilo ukuthola ukuthi i-anti-MESO antigen receptor CAR T-cell therapy ingasetshenziswa yini ukwelapha umdlavuza we-epithelial ovarian obuye wabuya noma oyekile ukuphendula komunye.

I-mirvetuximab soravtansine-gyn

I-Mirvetuximab soravtansine-gynx inikezwa ukugunyazwa okusheshayo kwe-FRα positive, i-platinum-resistant epithelial ovarian, fallopian tube, noma umdlavuza we-peritoneal

Novemba 2022: Ezigulini ezikhulile ezibe nemithi yokwelashwa ehleliwe eyodwa kuya kwezintathu futhi ezine-folate receptor alpha (FR) positive, i-epithelial epithelial ovarian engamelana ne-platinum, ishubhu le-fallopian, noma umdlavuza we-peritoneal oyinhloko, i-F.

I-Lancet, I-Mekinist, Tamoxifen, I-Trametinib

Ukwelashwa okusha kukhonjwe ebangeni eliphansi kanye nomdlavuza we-serous ovarian

Meyi 2022: I-Trametinib ingaba yindinganiso entsha yokunakekelwa komdlavuza we-serous ovarian (Mekinist) ovelayo. Ngokusho kokutholwe ocwaningweni olushicilelwe kumagazini kaFebhuwari 2022 weThe Lancet, i-trametinib yahlula yomibili i-chemotherapy kanye.

I-Cytalux, I-NCT03180307, i-pafolacianine, Amalabhorethri ahlosiwe

I-Pafolacianine ivunyelwe ukukhomba izilonda zomdlavuza we-ovarian oyingozi

Ngo-Jan 2022: I-Pafolacianine (Cytalux, On Target Laboratories, LLC), i-ejenti yokubona ngamehlo, inikezwe ilayisense yiFood and Drug Administration yeziguli ezikhulile ezinomdlavuza wesibeletho njenge-adjuvant yokutholwa kokusebenza ngokubambisana.

I-Niraparib

INiraparib ifinyelela imiphumela emangalisayo yomdlavuza we-ovari nowebele

Umdlavuza webele nowama-ovariUma ngabe uyisiguli somdlavuza webele nowe-ovari, kwenzeka ukuthi uthole ukuthi ungumdlavuza wokuguquka kwezinguquko kwe-BRCA1 / 2 ngemuva kokuphasa ukuhlolwa kofuzo, futhi impilo yakho iyasindiswa. Ngokusho kweGlobal Oncolog ..

I-Acalabrutunib, I-Avelumab, Ukwelashwa kwenqola, Dabrafanib, UKymriah, Izidakamizwa zakamuva, I-Midostaurin, I-Niraparib, I-Pembrolizumab, UTecartus, Unyusibhabha, I-Trametinib, USFDA

Izidakamizwa zakamuva ekwelapheni umdlavuza

July 2021: Check out the latest drugs in the treatment of cancer. Every year, after examining the trials and other important factors, the USFDA approves drugs, and thus cancer patients can now believe that a cure is very near. ..